UiPath Q2 Earnings Coverage Wrap-Up

UiPath just reported earnings, with shares initially up 12% following the report. Here are the key numbers:

• Revenue: $410.26M vs. $397.85M expected
• Adjusted EPS: $0.15 vs. $0.15 expected

Quick Read:

UiPath beat revenue expectations by roughly 3% while adjusted EPS came in exactly in line with Wall Street estimates.

The 12% initial surge suggests investors like the top-line momentum, with revenue growing 13% year over year as Wall Street looks for evidence that UiPath’s agentic AI strategy is accelerating growth.

Bull Case: Momentum, Margins, and Agentic Traction

• Consistent revenue beats: Q2 FY26 by 4.14%, Q3 FY26 by 4.64%, Q4 FY26 by 3.51%, Q1 FY27 by 5.26%, with Q1 revenue of $418 million, up 17%.
• 16 of the top 20 deals included AI, and AI expansion deals ran six times larger.
• GAAP profitability arrived for the first time, with Q1 non-GAAP operating margin at 22%.
• EPS revisions skew positive: 10 upward vs. 5 downward in 30 days.

Bear Case: High Bar, Decelerating Growth

• Shares are up 37.85% in one month, raising the setup risk.
• ARR growth is stuck near 11%-12%, well below prior levels.
• Q1 EPS missed by 5.48%, and analysts remain 16 Hold vs. 3 Buy.
• Insider direction is selling, an odd counterpoint to the rally.

With UiPath (NYSE:PATH) reporting after the close, here is what to listen for on the 5:00 PM ET call.

Top 5 Analyst Questions

1. Is net new ARR reaccelerating above the $49 million posted in Q1?
2. How much is agentic AI contributing, given 16 of the top 20 deals already include it?
3. Path to the 30% long-term non-GAAP margin target?
4. Competitive wins versus Microsoft Power Automate and Salesforce Agentforce?
5. Pace of buybacks after $243.8M repurchased in Q1?

Key Topics and Buzzwords

• Maestro Case, UiPath for Coding Agents, WorkFusion contribution, outcome-based pricing.
• Listen for “orchestration,” “deterministic plus agentic,” “pilot to production.”

Red Flags

• ARR at the low end of $1.929B-$1.934B.
• DBNR slipping below 109%.
• Any full-year guide trim versus the $1.776B-$1.781B range, which would jeopardize the 37.85% one-month rally.

Insider Activity Scorecard

Insider activity at UiPath (NYSE:PATH) over the past 90 days skewed decisively toward selling.

• CEO Daniel Dines’ August 19 disposal of over 1.4 million shares dwarfed every other filing.
• Chief Accounting Officer Hitesh Ramani added back-to-back sales in the mid-$16s.
• July 1 dispositions from Gupta, Malpani, and Legal Chief Brad Brubaker at $10.87 appear tied to vesting.

The only acquisitions were six identical 19,175-share director grants on June 25 at $0.00, reflecting equity awards rather than open-market conviction. Dashboard data confirms net insider direction is selling.

With shares up 37.85% in a month, executives leaned into strength rather than adding exposure ahead of tonight’s earnings report, a caution flag against the setup.

UiPath is expected to report fiscal Q2 2027 earnings at 4:10 PM ET, with Wall Street looking for evidence that its agentic AI push is translating into stronger recurring revenue growth.

Management has guided for revenue of $395-$400 million and ARR between roughly $1.929-$1.934 billion. Investors will also be watching net new ARR, with a figure above roughly $49 million providing another signal that growth is accelerating.

The stakes are high after UiPath shares soared around 40% over the past month. A higher full-year ARR outlook could validate the rally and strengthen the case that UiPath is evolving from a traditional automation vendor into a broader enterprise AI orchestration platform.

A guidance cut would tell a very different story and could put much of the stock’s recent rally at risk.